Bradley Merrill Thompson, Strategic Advisor with EBG Advisors and Member of the Firm at Epstein Becker Green, was a featured guest on WBUR, in “Why Congress Quietly Just Gave the FDA More Power,” by Claire Donnelly and Meghna Chakrabarti.
Following is an excerpt:
- Zachary Brennan, senior editor at Endpoints News, where he covers the U.S. regulatory agency.
- Randall Stafford, professor of medicine at the Stanford School of Medicine.
- Brad Thompson, attorney at the firm Epstein Becker Green who counsels medical device and drug product companies on FDA regulatory issues. …